Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was formerly known as PI Drugs & Pharmaceuticals Ltd. and changed its name to Sequent Scientific Limited in October 2009. The company was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.
Metrics to compare | SEQU | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSEQUPeersSector | |
---|---|---|---|---|
P/E Ratio | 199.9x | 12.3x | −0.5x | |
PEG Ratio | 1.25 | 0.00 | 0.00 | |
Price/Book | 6.2x | 1.3x | 2.6x | |
Price / LTM Sales | 2.8x | 1.3x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 43.4% | |
Fair Value Upside | Unlock | 6.4% | 7.1% | Unlock |